Oresković K - Search Results

1

Modulation of neutrophil and inflammation markers in chronic obstructive pulmonary disease by short-term azithromycin treatment.

Parnham MJ, Culić O, Eraković V, Munić V, Popović-Grle S, Barisić K, Bosnar M, Brajsa K, Cepelak I, Cuzić S, Glojnarić I, Manojlović Z, Novak-Mircetić R, Oresković K, Pavicić-Beljak V, Radosević S, Sucić M. Parnham MJ, et al. Among authors: oreskovic k. Eur J Pharmacol. 2005 Jul 4;517(1-2):132-43. doi: 10.1016/j.ejphar.2005.05.023. Eur J Pharmacol. 2005. PMID: 15964564 Clinical Trial.

2

Antibiotics for asthma?

Parnham MJ, Oreskovic K. Parnham MJ, et al. Among authors: oreskovic k. Pediatr Pulmonol Suppl. 2004;26:52. doi: 10.1002/ppul.70048. Pediatr Pulmonol Suppl. 2004. PMID: 15029594 No abstract available.

3

Azithromycin versus amoxicillin/clavulanate in the treatment of acute sinusitis.

Klapan I, Culig J, Oresković K, Matrapazovski M, Radosević S. Klapan I, et al. Among authors: oreskovic k. Am J Otolaryngol. 1999 Jan-Feb;20(1):7-11. doi: 10.1016/s0196-0709(99)90044-3. Am J Otolaryngol. 1999. PMID: 9950107 Clinical Trial.

4

Azithromycin: single 1.5 g dose in the treatment of patients with atypical pneumonia syndrome--a randomized study.

Schönwald S, Kuzman I, Oresković K, Burek V, Skerk V, Car V, Bozinović D, Culig J, Radosević S. Schönwald S, et al. Among authors: oreskovic k. Infection. 1999 May-Jun;27(3):198-202. doi: 10.1007/BF02561528. Infection. 1999. PMID: 10378132 Clinical Trial.

5

The novel antifungal agent PLD-118 is neither metabolized by liver microsomes nor inhibits cytochrome P450 in vitro.

Parnham MJ, Bogaards JJ, Schrander F, Schut MW, Oresković K, Mildner B. Parnham MJ, et al. Among authors: oreskovic k. Biopharm Drug Dispos. 2005 Jan;26(1):27-33. doi: 10.1002/bdd.429. Biopharm Drug Dispos. 2005. PMID: 15593345

6

Azithromycin: 3-day versus 5-day course in the treatment of respiratory tract infections in children. Croatian Azithromycin Study Group.

Ficnar B, Huzjak N, Oreskovic K, Matrapazovski M, Klinar I. Ficnar B, et al. Among authors: oreskovic k. J Chemother. 1997 Feb;9(1):38-43. doi: 10.1179/joc.1997.9.1.38. J Chemother. 1997. PMID: 9106016 Clinical Trial.

7

Azithromycin vs doxycycline in the treatment of inclusion conjunctivitis.

Katusic D, Petricek I, Mandic Z, Petric I, Salopek-Rabatic J, Kruzic V, Oreskovic K, Sikic J, Petricek G. Katusic D, et al. Among authors: oreskovic k. Am J Ophthalmol. 2003 Apr;135(4):447-51. doi: 10.1016/s0002-9394(02)02094-9. Am J Ophthalmol. 2003. PMID: 12654359 Clinical Trial.

8

Azithromycin in the treatment of pneumonias caused by Chlamydia spp: a retrospective study.

Kuzman I, Oresković K, Schönwald S, Culig J. Kuzman I, et al. Among authors: oreskovic k. Int J Clin Pharmacol Res. 1996;16(4-5):103-7. Int J Clin Pharmacol Res. 1996. PMID: 9172008

9

[Patient compliance in the treatment of respiratory tract infections].

Pavić-Sladoljev D, Oresković K. Pavić-Sladoljev D, et al. Among authors: oreskovic k. Lijec Vjesn. 1997 Jul;119(7):193-200. Lijec Vjesn. 1997. PMID: 9471478 Croatian.

10

Pseudocholinesterase in alloxan-diabetic rats.

Oresković K, Kunec-Vajić E. Oresković K, et al. Res Commun Chem Pathol Pharmacol. 1992 Oct;78(1):117-20. Res Commun Chem Pathol Pharmacol. 1992. PMID: 1462046

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

13 results

Search Page